{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:04:49Z","timestamp":1780553089766,"version":"3.54.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Highly purified adenovirus preparations are essential for fundamental research and therapeutic use. However, the impact of viral concentration during CsCl gradient ultracentrifugation on virion integrity is poorly understood, and this incomplete mechanistic understanding may adversely affect product quality and constrain further advances in research. In this study, we examined how viral input affects adenovirus infectivity, cytotoxicity, yield, and structural integrity using transmission electron microscopy and analysis tools. High-concentration preparations (AdV-HC) showed significant aggregation, capsid damage, and considerably lower TCID\u2085\u2080 values, while optimally concentrated preparations (AdV-OC) preserved intact icosahedral structures and high infectivity. Efforts to reverse aggregation failed, showing that excessive viral concentration during purification causes irreversible structural harm. These findings indicate that overloading during CsCl ultracentrifugation promotes vector aggregation, thereby compromising virion stability and biological activity. To preserve structural integrity and ensure consistent performance, we recommend maintaining the final purified vector concentration at or below 2\u202fmg\/mL. Based on this threshold, we defined theoretical optimal optical density (OD) ranges for adenovirus concentration in cell lysates prior to ultracentrifugation to minimize vector aggregation during purification. Therefore, this study provides a simple and effective strategy for improving the consistency, purity, and infectivity of adenovirus preparations for both research and clinical applications.<\/jats:p>","DOI":"10.3389\/fmicb.2026.1845210","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:34:59Z","timestamp":1780551299000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["High adenoviral vector concentration can cause irreversible aggregation during CsCl gradient ultracentrifugation"],"prefix":"10.3389","volume":"17","author":[{"given":"Haidong","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology, Virology, Ume\u00e5 University","place":["Ume\u00e5, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Fang","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Virology, Ume\u00e5 University","place":["Ume\u00e5, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bpc.2007.09.004","article-title":"Protein precipitation and denaturation by dimethyl sulfoxide","volume":"131","author":"Arakawa","year":"2007","journal-title":"Biophys. Chem."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.omto.2016.11.003","article-title":"Oncolytic group B adenovirus enadenotucirev mediates non-apoptotic cell death with membrane disruption and release of inflammatory mediators","volume":"4","author":"Dyer","year":"2017","journal-title":"Mol Ther Oncolytics"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF01317899","article-title":"Adenovirus aggregation and preservation in extracellular environment","volume":"59","author":"Galdiero","year":"1979","journal-title":"Arch. Virol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.virol.2016.04.029","article-title":"Replication-competent human adenovirus 11p vectors can propagate in Vero cells","volume":"495","author":"Gokumakulapalle","year":"2016","journal-title":"Virology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1093\/emboj\/cdf442","article-title":"Acid-induced movements in the glycoprotein shell of an alphavirus turn the spikes into membrane fusion mode","volume":"21","author":"Haag","year":"2002","journal-title":"EMBO J."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0167-4838(91)90563-F","article-title":"Beware of proteins in Dmso","volume":"1078","author":"Jackson","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12560-016-9232-x","article-title":"Aggregation of adenovirus 2 in source water and impacts on disinfection by chlorine","volume":"8","author":"Kahler","year":"2016","journal-title":"Food Environ Virol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.virol.2004.07.018","article-title":"Human hematopoietic (CD34+) stem cells possess high-affinity receptors for adenovirus type 11p","volume":"328","author":"Mei","year":"2004","journal-title":"Virology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.virol.2016.07.026","article-title":"Complete replication-competent adenovirus 11p vectors with E1 or E3 insertions show improved heat stability","volume":"497","author":"Mei","year":"2016","journal-title":"Virology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/v14020438","article-title":"Viral aggregation: the knowns and unknowns","volume":"14","author":"Pradhan","year":"2022","journal-title":"Viruses"},{"key":"ref11","first-page":"5","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jps.20496","article-title":"Effect of pH and ionic strength on the physical stability of adenovirus type 5","volume":"95","author":"Rexroad","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1089\/hum.2007.124","article-title":"Replication-competent Ad11p vector (RCAd11p) efficiently transduces and replicates in hormone-refractory metastatic prostate cancer cells","volume":"20","author":"Sandberg","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1128\/JVI.74.6.2567-2583.2000","article-title":"Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector","volume":"74","author":"Shayakhmetov","year":"2000","journal-title":"J. Virol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"16088","DOI":"10.1038\/s41598-021-94573-y","article-title":"A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation","volume":"11","author":"Stepanenko","year":"2021","journal-title":"Sci. Rep."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.118.2.295","article-title":"Structure of type 5 adenovirus. I. Antigenic relationship of virus-structural proteins to virus-specific soluble antigens from infected cells","volume":"118","author":"Wilcox","year":"1963","journal-title":"J. Exp. Med."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/mt.2011.242","article-title":"Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11","volume":"20","author":"Wong","year":"2012","journal-title":"Mol. Ther."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.18632\/oncotarget.26754","article-title":"An oncolytic adenovirus 11p vector expressing adenovirus death protein in the E1 region showed significant apoptosis and tumour-killing ability in metastatic prostate cells","volume":"10","author":"Wu","year":"2019","journal-title":"Oncotarget"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/hum.2017.218","article-title":"The first approved gene therapy product for Cancer ad-p53 (Gendicine): 12 years in the clinic","volume":"29","author":"Zhang","year":"2018","journal-title":"Hum. Gene Ther."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1845210\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:35:00Z","timestamp":1780551300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1845210\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":19,"alternative-id":["10.3389\/fmicb.2026.1845210"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1845210","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"article-number":"1845210"}}